跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,348 条关于
“amyloid oligomers”
全部
5,348
临床试验
4,314
药物
148
机构
3
资讯
883
去年
Acumen's ACU193 Shows Promise as First-in-Class Alzheimer's Treatment Targeting Toxic Amyloid Oligomers
去年
Alzheon's ALZ-801 Shows Promise in Reducing Phosphorylated Tau and Enhancing Memory in Early Alzheimer's Disease
5个月前
Alzheon Initiates Phase 1 Trial of ALZ-507, Next-Generation Oral Alzheimer's Drug with APOE4 Corrector Mechanism
去年
Acumen Pharmaceuticals Utilizes pTau217 Assay in Sabirnetug Phase 2 Alzheimer's Trial
去年
ProMIS Neurosciences Initiates Phase 1b Trial of PMN310 for Alzheimer's Disease
去年
Acumen's Sabirnetug Shows Promise in Phase 1 Alzheimer's Trial
去年
ProMIS Neurosciences' PMN310 Shows Promise in Phase 1a Alzheimer's Trial
去年
Acumen Pharmaceuticals' pTau217 Assay Streamlines Alzheimer's Clinical Trials
9个月前
Northwestern's NU-9 Drug Prevents Alzheimer's Pathology in Pre-Symptomatic Animal Model
9个月前
Two Novel Alzheimer's Therapies Advance in Phase 2 Trials: Oral PRI-002 and TREM2-Targeting VHB937
第 1 页,共 89 页
上一页
下一页